JCR Pharmaceuticals Co., Ltd.
JPX: 4552.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Toru Ashida
- Employees
- 934
- Headquarters
- Ashiya, Japan
- IPO year
- 2005
- Market cap
- ¥66.4B
- Website
- https://www.jcrpharm.co.jp
Loading 4552…
Loading profile data…Frequently asked questions about 4552
What does JCR Pharmaceuticals Co., Ltd. (4552.T) do?
JCR Pharmaceuticals Co., Ltd., a specialty pharmaceuticals company, engages in the research, development, manufacture, import and export, and sale of pharmaceutical products, regenerative medicines, and drug substances in Japan. It offers various therapeutic products, including GROWJECT used for the treatment of growth hormone deficiency and sho...
Where does 4552.T trade?
JCR Pharmaceuticals Co., Ltd. (4552.T) trades on the Tokyo Stock Exchange.
What sector is 4552.T in?
JCR Pharmaceuticals Co., Ltd. (4552.T) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of JCR Pharmaceuticals Co., Ltd.?
Toru Ashida is the chief executive officer of JCR Pharmaceuticals Co., Ltd. (4552.T).
Where is JCR Pharmaceuticals Co., Ltd. headquartered?
JCR Pharmaceuticals Co., Ltd. is headquartered in Japan.
Does 4552.T pay a dividend?
Yes — JCR Pharmaceuticals Co., Ltd. (4552.T) paid a trailing twelve-month dividend of JPY 20.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 4552.T go public?
JCR Pharmaceuticals Co., Ltd. (4552.T) completed its initial public offering in 2005.